You can open publications which are freely available by clicking on the relevant links. Other articles should be accessible, with an Athens username, via The Knowledge Network.
Publications
British Medical Association. Reporting adverse drug reactions: a guide for healthcare professionals. London: BMA; 2006.
Metters J (Chair, Steering Committee). Report of an independent review of access to the Yellow Card Scheme. London: TSO; 2004.
Medicines and Healthcare products Regulatory Agency. Trends in UK spontaneous adverse drug reaction (ADR) reporting between 2008-2012. London: MHRA; 2014.
Medicines and Healthcare products Regulatory Agency. Contribution of Yellow Cards to identifying safety issues. London: MHRA; 2017.
National Prescribing Centre. 10 top tips for GPs: strategies for safer prescribing. Liverpool: NPC; 2011.
National Institute for Health and Care Excellence Clinical Knowledge Summaries. Adverse drug reactions. London: NICE; 2012.
Medicines and Healthcare products Regulatory Agency. Send and receive information on adverse drug reactions (ADRs). London: MHRA; 2017.
Medicines and Healthcare products Regulatory Agency. New guidance on reporting suspected adverse reactions in children. London: MHRA; 2014
Maxwell S. Pharmacovigilance during the COVID-19 pandemic and beyond.
Journal Articles
Kurz X, Perez-Gutthann S, the ENCePP Steering Group. Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Netowrk of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). Pharmacoepidemiol Drug Saf. 2018;1-11.
Aldeyab M, Noble, S. C, Cuthbert, M, Maxwell, S and Boyter, A. Assessment of the impact of the Scottish public health campaign on patient reporting of adverse drug reactions. Drugs & Therapy Perspectives, 2016, Vol 32 (5); pp 209-218.
Avery AJ, Anderson C, Bond CM, Fortnum H, Gifford A, Hannaford PC, Hazell L, Krska J, Lee AJ, McLernon DJ, Murphy E, Shakir S, Watson MC. Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess 2011; 15(20): 1-234.
Cox AR, Anton C, McDowell, SE, Marriott JF, Ferner RE. Correlates of spontaneous reporting of adverse drug reactions within primary care: the paradox of low prescribers who are high reporters. Br J Clin Pharmacol 2010; 69(5): 529-534.
Davies EC, Green CF, Mottram DR, Rowe PH, Pirmohamed M. Emergency readmissions to hospital due to adverse drug reactions within 1 year of the index admission. Br J Clin Pharmacol 2010; 70(5): 749-55.
Green R, Maxwell S. The medic’s guide to prescribing: minimising adverse drug reactions. Student BMJ 2007; 15: 222-224.
Smyth R, Gargon E, Kirkham J, Creswell L, Golder S, Smyth R, Williamson P. Adverse drug reactions in children – a systematic review. PLoS ONE 2012; 7(3): e24061.
Consumers of natural health products: natural-born pharmacovigilantes? BMC Altern Med 2010; 10:8.
Wooten JM. Adverse drug reactions: part I. South Med J 2010;103(10):1025-28.
Wooten JM. Adverse drug reactions: part II. South Med J 2010;103(11):1138-1145.
Unpublished Resources
Brown N. Evaluation of the Community Pharmacy Patient Yellow Card Reporting Campaign by the Yellow Card Centre Scotland. 2010.
Posters
See the posters section of the YCCS Reports page for more information on academic posters published by or in collaboration with Yellow Card Centre Scotland.